TY - JOUR T1 - Aspirin for primary prevention of atherosclerotic cardiovascular events JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 300 LP - 311 DO - 10.3949/ccjm.87a.19045 VL - 87 IS - 5 AU - Aldo L. Schenone AU - A. Michael Lincoff Y1 - 2020/05/01 UR - http://www.ccjm.org/content/87/5/300.abstract N2 - Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk. ER -